The Hereditary Renal Cell Carcinoma 3;8 Translocation Fuses FHIT to a Patched-Related Gene, TRC8

The 3;8 chromosomal translocation, t(3;8)(p14.2;q24.1), was described in a family with classical features of hereditary renal cell carcinoma. Previous studies demonstrated that the 3p14.2 breakpoint interrupts the fragile histidine triad gene (FHIT) in its 5′noncoding region. However, evidence that...

Full description

Saved in:
Bibliographic Details
Published in:Proceedings of the National Academy of Sciences - PNAS Vol. 95; no. 16; pp. 9572 - 9577
Main Authors: Gemmill, Robert M., West, James D., Boldog, Ferenc, Tanaka, Naotake, Robinson, Linda J., Smith, David I., Li, Frederick, Drabkin, Harry A.
Format: Journal Article
Language:English
Published: United States National Academy of Sciences of the United States of America 04-08-1998
National Acad Sciences
National Academy of Sciences
The National Academy of Sciences
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The 3;8 chromosomal translocation, t(3;8)(p14.2;q24.1), was described in a family with classical features of hereditary renal cell carcinoma. Previous studies demonstrated that the 3p14.2 breakpoint interrupts the fragile histidine triad gene (FHIT) in its 5′noncoding region. However, evidence that FHIT is causally related to renal or other malignancies is controversial. We now show that the 8q24.1 breakpoint region encodes a 664-aa multiple membrane spanning protein, TRC8, with similarity to the hereditary basal cell carcinoma/segment polarity gene, patched. This similarity involves two regions of patched, the putative sterol-sensing domain and the second extracellular loop that participates in the binding of sonic hedgehog. In the 3;8 translocation, TRC8 is fused to FHIT and is disrupted within the sterol-sensing domain. In contrast, the FHIT coding region is maintained and expressed. In a series of sporadic renal carcinomas, an acquired TRC8 mutation was identified. By analogy to patched, TRC8 might function as a signaling receptor and other pathway members, to be defined, are mutation candidates in malignant diseases involving the kidney and thyroid.
Bibliography:Communicated by David Marshall Prescott, University of Colorado, Boulder, CO
To whom reprint requests should be addressed. e-mail: gemmill@loki.uchsc.edu.
Present address: CuraGen Corporation, 12085 Research Drive, Alachua, FL 32615.
ISSN:0027-8424
1091-6490
DOI:10.1073/pnas.95.16.9572